Clinical Trials

Study Title:
A Phase 2 Open-Label Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Subjects With Myelofibrosis

For more information about the trial above please contact the study team:

Principal Investigator, Praneeth Baratam, at

Study Coordinator, Sarah Britton, at, or please call +1 843-792-8856.

Trial opened at the following institutions: Medical University of South Carolina